How is Spinal Muscular Atrophy diagnosed?

Spinal Muscular Atrophy (SMA) is primarily diagnosed through definitive genetic testing that identifies the deletion or mutation of the SMN1 gene. While physical examinations and clinical suspicion initiate the process, genetic confirmation remains the gold standard for confirming an Spinal Muscular Atrophy diagnosis.

How is Spinal Muscular Atrophy diagnosed?

The diagnostic journey for Spinal Muscular Atrophy typically begins when a physician observes symptoms such as muscle weakness, hypotonia (floppy muscle tone), or the loss of motor milestones. Because these symptoms can mimic other neuromuscular disorders, clinicians follow a structured approach. The process usually involves a thorough neurological examination to assess muscle strength and reflexes, followed by a blood test for genetic analysis. In the vast majority of cases—approximately 95% to 98%—a simple blood test detecting the homozygous deletion of the SMN1 gene confirms the diagnosis of Spinal Muscular Atrophy.

What tests are used to confirm the diagnosis?

While genetic testing is definitive, other clinical investigations may be utilized if the genetic results are inconclusive or to assess the severity of the condition. Key diagnostic tools include:

• Genetic Testing: Quantitative PCR or MLPA analysis to detect SMN1 gene deletions and determine the copy number of the SMN2 gene (which influences disease severity).


• Electromyography (EMG): A test that measures the electrical activity of muscles to detect signs of denervation.


• Nerve Conduction Studies: Often used to differentiate Spinal Muscular Atrophy from peripheral neuropathies.


• Creatine Kinase (CK) levels: A blood test that may show mildly elevated levels, though usually much lower than in muscular dystrophies.


• Muscle Biopsy: Rarely performed today due to the high accuracy of genetic testing, but historically used to identify characteristic muscle atrophy.

Why is there often a "diagnostic odyssey" for patients?

We recognize that the path to a diagnosis can be incredibly isolating and frustrating. Many families face a "diagnostic odyssey," spending months or even years visiting various specialists before receiving a final answer for Spinal Muscular Atrophy. This occurs because the early signs of SMA can be subtle or mistaken for general developmental delays. Furthermore, because SMA is a rare disease, primary care physicians may not encounter it frequently. If you feel your concerns are not being addressed, it is vital to seek a referral to a neuromuscular specialist or a pediatric neurologist who has experience with rare motor neuron diseases.

What conditions are considered in a differential diagnosis?

Because Spinal Muscular Atrophy presents with weakness and hypotonia, clinicians must rule out several other conditions, including Congenital Myopathies, Pompe disease, and certain muscular dystrophies. Distinguishing between these is essential, as the management strategies for Spinal Muscular Atrophy—which now include life-changing gene therapies and disease-modifying treatments—are specific to the genetic cause of the condition.

Next steps

• Consult a board-certified pediatric or adult neurologist specializing in neuromuscular disorders.


• Request a SMN1 genetic test if you have persistent concerns about muscle weakness.


• Connect with the 972 members of our Spinal Muscular Atrophy community at DiseaseMaps.org to share experiences and find support.


• Keep a detailed log of symptom progression and motor milestones to assist your medical team.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Spinal Muscular Atrophy.


• Orphanet: Spinal Muscular Atrophy (ORPHA:83395).


• Cure SMA: Understanding SMA Diagnosis and Testing.


• OMIM (Online Mendelian Inheritance in Man): Spinal Muscular Atrophy (#253300).